Literature DB >> 23193052

The mTORC1 signaling repressors REDD1/2 are rapidly induced and activation of p70S6K1 by leucine is defective in skeletal muscle of an immobilized rat hindlimb.

Andrew R Kelleher1, Scot R Kimball, Michael D Dennis, Rudolf J Schilder, Leonard S Jefferson.   

Abstract

Limb immobilization, limb suspension, and bed rest cause substantial loss of skeletal muscle mass, a phenomenon termed disuse atrophy. To acquire new knowledge that will assist in the development of therapeutic strategies for minimizing disuse atrophy, the present study was undertaken with the aim of identifying molecular mechanisms that mediate control of protein synthesis and mechanistic target of rapamycin complex 1 (mTORC1) signaling. Male Sprague-Dawley rats were subjected to unilateral hindlimb immobilization for 1, 2, 3, or 7 days or served as nonimmobilized controls. Following an overnight fast, rats received either saline or L-leucine by oral gavage as a nutrient stimulus. Hindlimb skeletal muscles were extracted 30 min postgavage and analyzed for the rate of protein synthesis, mRNA expression, phosphorylation state of key proteins in the mTORC1 signaling pathway, and mTORC1 signaling repressors. In the basal state, mTORC1 signaling and protein synthesis were repressed within 24 h in the soleus of an immobilized compared with a nonimmobilized hindlimb. These responses were accompanied by a concomitant induction in expression of the mTORC1 repressors regulated in development and DNA damage responses (REDD) 1/2. The nutrient stimulus produced an elevation of similar magnitude in mTORC1 signaling in both the immobilized and nonimmobilized muscle. In contrast, phosphorylation of 70-kDa ribosomal protein S6 kinase 1 (p70S6K1) on Thr(229) and Thr(389) in response to the nutrient stimulus was severely blunted. Phosphorylation of Thr(229) by PDK1 is a prerequisite for phosphorylation of Thr(389) by mTORC1, suggesting that signaling through PDK1 is impaired in response to immobilization. In conclusion, the results show an immobilization-induced attenuation of mTORC1 signaling mediated by induction of REDD1/2 and defective p70S6K1 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23193052      PMCID: PMC3543567          DOI: 10.1152/ajpendo.00409.2012

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  55 in total

Review 1.  Regrowth of skeletal muscle atrophied from inactivity.

Authors:  Shuichi Machida; Frank W Booth
Journal:  Med Sci Sports Exerc       Date:  2004-01       Impact factor: 5.411

2.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

Authors:  Ken Inoki; Yong Li; Tian Xu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

3.  Antecedents of frailty over three decades in an older cohort.

Authors:  W J Strawbridge; S J Shema; J L Balfour; H R Higby; G A Kaplan
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  1998-01       Impact factor: 4.077

4.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.

Authors:  S C Bodine; T N Stitt; M Gonzalez; W O Kline; G L Stover; R Bauerlein; E Zlotchenko; A Scrimgeour; J C Lawrence; D J Glass; G D Yancopoulos
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

5.  AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.

Authors:  Douglas R Bolster; Stephen J Crozier; Scot R Kimball; Leonard S Jefferson
Journal:  J Biol Chem       Date:  2002-05-07       Impact factor: 5.157

6.  REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.

Authors:  Leif W Ellisen; Kate D Ramsayer; Cory M Johannessen; Annie Yang; Hideyuki Beppu; Karolina Minda; Jonathan D Oliner; Frank McKeon; Daniel A Haber
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

7.  Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation.

Authors:  J C Anthony; T G Anthony; S R Kimball; T C Vary; L S Jefferson
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

8.  Contribution of insulin to the translational control of protein synthesis in skeletal muscle by leucine.

Authors:  Joshua C Anthony; Charles H Lang; Stephen J Crozier; Tracy G Anthony; David A MacLean; Scot R Kimball; Leonard S Jefferson
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-05       Impact factor: 4.310

9.  Responsiveness of cell signaling pathways during the failed 15-day regrowth of aged skeletal muscle.

Authors:  R Tyler Morris; Espen E Spangenburg; Frank W Booth
Journal:  J Appl Physiol (1985)       Date:  2003-09-26

10.  Skeletal muscle strength as a predictor of all-cause mortality in healthy men.

Authors:  E Jeffrey Metter; Laura A Talbot; Matthew Schrager; Robin Conwit
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-10       Impact factor: 6.053

View more
  48 in total

1.  Slow recovery of the impaired fatigue resistance in postunloading mouse soleus muscle corresponding to decreased mitochondrial function and a compensatory increase in type I slow fibers.

Authors:  Han-Zhong Feng; Xuequn Chen; Moh H Malek; J-P Jin
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-07       Impact factor: 4.249

2.  Age-related differences in lean mass, protein synthesis and skeletal muscle markers of proteolysis after bed rest and exercise rehabilitation.

Authors:  Ruth E Tanner; Lucille B Brunker; Jakob Agergaard; Katherine M Barrows; Robert A Briggs; Oh Sung Kwon; Laura M Young; Paul N Hopkins; Elena Volpi; Robin L Marcus; Paul C LaStayo; Micah J Drummond
Journal:  J Physiol       Date:  2015-07-31       Impact factor: 5.182

3.  Depression of leukocyte protein synthesis, immune function and growth performance induced by high environmental temperature in broiler chickens.

Authors:  Nancy N Kamel; Ayman M H Ahmed; Gamal M K Mehaisen; Magdi M Mashaly; Ahmed O Abass
Journal:  Int J Biometeorol       Date:  2017-04-28       Impact factor: 3.787

Review 4.  Disuse-induced muscle wasting.

Authors:  Sue C Bodine
Journal:  Int J Biochem Cell Biol       Date:  2013-06-22       Impact factor: 5.085

5.  Reduced REDD1 expression contributes to activation of mTORC1 following electrically induced muscle contraction.

Authors:  Bradley S Gordon; Jennifer L Steiner; Charles H Lang; Leonard S Jefferson; Scot R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

6.  p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization.

Authors:  Daniel K Fox; Scott M Ebert; Kale S Bongers; Michael C Dyle; Steven A Bullard; Jason M Dierdorff; Steven D Kunkel; Christopher M Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-03       Impact factor: 4.310

7.  Loss of REDD1 augments the rate of the overload-induced increase in muscle mass.

Authors:  Bradley S Gordon; Chang Liu; Jennifer L Steiner; Gustavo A Nader; Leonard S Jefferson; Scot R Kimball
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-07-27       Impact factor: 3.619

Review 8.  Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism.

Authors:  Bradley S Gordon; Jennifer L Steiner; David L Williamson; Charles H Lang; Scot R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-17       Impact factor: 4.310

Review 9.  Role of amino acid transporters in amino acid sensing.

Authors:  Peter M Taylor
Journal:  Am J Clin Nutr       Date:  2013-11-27       Impact factor: 7.045

Review 10.  Mitochondrial dysfunction induces muscle atrophy during prolonged inactivity: A review of the causes and effects.

Authors:  Hayden Hyatt; Rafael Deminice; Toshinori Yoshihara; Scott K Powers
Journal:  Arch Biochem Biophys       Date:  2018-11-16       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.